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Abstract
Background—Exposure to World Trade Center (WTC) dust and fumes is associated with onset
of asthma-like respiratory symptoms in rescue and recovery workers and exposed community
members. Eosinophilic inflammation with increased lung and peripheral eosinophils has been
described in subpopulations with asthma. We hypothesized that persistent asthma-like symptoms
in WTC-exposed individuals would be associated with systemic inflammation characterized by
peripheral eosinophils.
Methods—The WTC Environmental Health Center (EHC) is a treatment program for local
residents, local workers, and clean-up workers with presumed WTC-related symptoms. Patients
undergo a standardized evaluation including questionnaires and complete blood count. Between
9/2005–3/2009, 2461 individuals enrolled in the program and were available for analysis.
Individuals with pre-existing respiratory symptoms or lung disease diagnoses prior to 9/11/2001
and current or significant tobacco use were excluded.
Results—1508 individuals met inclusion criteria. These patients had a mean age of 47 years,
were mostly female (51%) and had a diverse race/ethnicity. Respiratory symptoms that developed
after WTC dust/fume exposure and remained persistent included dyspnea on exertion (68%),
cough (57%), chest tightness (46%), and wheeze (33%). A larger percentage of those with wheeze
had elevated peripheral eosinophils compared to those without wheeze (21% vs. 13%, p<0.0001).
Individuals with elevated peripheral eosinophils were more likely to have airflow obstruction on
spirometry (16% vs. 7%, p = 0.0003).
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Conclusions—Peripheral eosinophils were associated with wheeze and reduced lung function in
a diverse WTC-exposed population. These data suggest that eosinophils may participate in lung
inflammation in this population with symptoms consistent with WTC-related asthma.
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Introduction
The destruction of the World Trade Center (WTC) towers on September 11, 2001 resulted in
the massive release of dust, gas, and fumes with potential environmental and occupational
exposures for thousands of individuals. Adverse health effects from these exposures are well
described for rescue and recovery workers with work-related exposure, as well as for
community members including local workers in the WTC towers and in surrounding
commercial spaces, and residents of the surrounding buildings (1–9) (10–11). Community
members, including over 360,000 local workers and over 57,000 residents south of Canal
Street in lower Manhattan alone have been estimated to have had potential for dust and fume
exposure (12). Exposure to the dust cloud from the collapsing buildings on 9/11/01 and
exposure to resuspended dusts and ongoing fumes have been shown to be associated with
new onset lower respiratory symptoms in local community members (13) (14).
Most studies of WTC-exposed populations demonstrate the presence of new onset and
persistent lower respiratory tract symptoms (LRS) of cough, wheeze, dyspnea on exertion
(DOE), or chest tightness. These symptoms have been described to persist at least five years
after their exposure (7–8, 10, 13, 15). Most patients in screening or treatment programs for
rescue workers or community members with potential for WTC dust/fume exposures have
been described to have normal spirometry, with only one third displaying abnormalities on
screening spirometry (3) (15). Airflow obstruction was identified in only a minority of
individuals in these studies; a low forced vital capacity (FVC) was a more common
abnormality (3, 15) (16). In a recent study of WTC-exposed community members, those
with LRS had an increase in abnormal spirometry and oscillometry measurements compared
to those without LRS symptoms; these lung function abnormalities were associated with
WTC-dust/fume exposure (17). Many rescue workers and responders, as well as community
members with LRS have persistent hyperresponsiveness (1–2) (9). Thus most patients have
been given a diagnosis of reactive airways dysfunction, irritant-induced asthma, or asthma.
However, not all patients clearly fit the diagnosis of asthma and in some patients sarcoidosis
and other interstitial lung diseases have also been described, suggesting a variety of
pathologic processes in WTC-exposed patients (18–20).
Few studies have examined biologic processes involved in WTC-related LRS. Rom et al.
reported a case of acute eosinophilic pneumonia in a firefighter with symptoms that
developed soon after the event (21). Fireman et al. reported an increase in both sputum
eosinophils and neutrophils in WTC-exposed firefighters that persisted one year after the
event (22). Elevated blood levels of pro-inflammatory cytokines, including granulocyte
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macrophage-colony stimulating factor, have been identifies in blood samples from
firefighters obtained soon after the event (23).
The WTC Environmental Health Center (WTC-EHC) is a treatment program for self-
referred community members (residents and individuals who worked in the area surrounding
the WTC) as well as for individuals involved in the clean-up of the surrounding area (clean-
up workers). These individuals undergo a standardized WTC-dust/fume exposure and
clinical evaluation including a complete blood count. Because of the role of eosinophils in
asthma, and the descriptions in the responder population, we hypothesized that new onset
and persistent LRS in patients enrolled in the WTC EHC would be associated with an
eosinophilic process reflected by elevated blood eosinophils.
Materials and Methods
Subjects
Patients were enrolled into the Bellevue WTC EHC as previously described (15). In brief,
patients self-referred in response to program information distributed by community-based
organizations and local news and advertisements. Enrollment criteria included exposure to
WTC dust, gas, or fumes as a local worker, resident, or cleanup worker in southern
Manhattan on or in the months after September 11, 2001 and the presence of a physical
symptom that occurred or was exacerbated after September 11. Patients who enrolled over
the 42 month period from September 2005 until March 2009 were included in the analysis.
Exclusion criteria for this analysis included the existence of respiratory symptoms or disease
prior to 9/11/2001 and active or significant past smoking history (≥ 5 pack-years). The study
was approved by the New York University School of Medicine IRB and all patients who
were analyzed signed consent.
Procedures
On enrollment in the program, patients were administered a multi-dimensional questionnaire
that queried demographics; exposure to WTC dust via occupation, work or residence and
symptoms, including their severity and temporal relationship relative to September 11, 2001.
A physical examination, mental health screen, and blood test, including automated complete
blood cell counts were performed. All individuals were initially referred for spirometry,
which was performed in accordance with American Thoracic Society/European Respiratory
Society standards on a Sensormedics spirometer (Yorba Linda, CA)(24). Lower respiratory
tract symptoms (LRS) were defined as cough, chest tightness, dyspnea on exertion (DOE),
daytime wheeze or nocturnal wheeze. “New onset” symptoms were defined to include those
that began after 9/11/01. “Persistent symptoms” were defined to be present at a frequency ≥
2 times each week in the month preceding entry into WTC EHC. Predicted values for forced
vital capacity (FVC), and forced expiratory volume in one second (FEV1) were derived from
NHANES III (25). Spirometry was categorized by spirometric pattern as normal, obstructed
(FEV1/FVC < LLN FEV1/FVC) or low FVC (FEV1/FVC > LLN FEV1/FVC and FVC <
LLN FVC) and these patterns were used for further analysis (26).
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We describe the population as a whole and after stratification by eosinophil percentage.
Descriptive statistics of counts and proportions were calculated for categorical variables.
Means and standard deviations were calculated for continuous variables. We performed
univariate analysis using the chi-square test for categorical variables, the t-test or Wilcoxon
rank-sum test for continuous variables. The percent eosinophils were dichotomized as high
eosinophils if ≥ 4% (high eos) vs. low eosinophils if < 4% (low eos), to reflect elevated and
normal values in the reference laboratory. Multivariate nominal logistic regression was
performed to examine the association between the spirometry patterns and the eosinophil
levels controlling for significant variables on univariate analysis (i.e., age and gender). P
values less than 0.05 were considered statistically significant. For each individual analysis,
individuals with missing values were excluded from the calculations. All statistical analyses
were conducted using JMP, version 7. (SAS Institute Inc., Cary, NC,).
Results
Patient Characteristics
Two thousand four hundred and sixty one patients greater than 17 years of age were
consecutively enrolled and signed consents between September 2005 and March 2009
(Figure 1). Nine hundred fifty-three patients were excluded for the presence of respiratory
symptoms or respiratory diagnosis prior to September 11, 2001 (n = 422) or current or ≥ 5
pack-year tobacco history (n = 531). The baseline demographics of the eligible patients (n =
1,508) are shown in Table 1. Although nearly equal, there were more women (51%) than
men. The mean age was 46.4 years, and the average body mass index (BMI) was 28.2. The
group was racially and ethnically diverse. Many (42%) reported being in the initial dust
cloud created as the buildings collapsed on 9/11.
The population was stratified into those with high eos (n = 216) and those with low eos (n =
1192). More males were in the high eos compared to low eos group (59 vs. 47%
respectively, p = 0.002). The high eos group was slightly older than the low eos group (44.7
± 0.9 years old vs. 46.7 ± 0.4, p = 0.03) but there was no significant difference in race/
ethnicity or BMI. Type of exposure was not associated with either high or low eos group as
there was no difference in initial WTC dust cloud exposure or when patients were
categorized by type of potential exposure category (i.e. resident, local worker, clean-up
worker). There was no difference in the results when absolute eosinophils per unit of volume
(>500 eosinophils/microliter of blood) was used (data not shown).
Lower respiratory symptoms and eosinophils
Most symptoms that patients reported upon entry into the WTC EHC related to the upper
and lower respiratory tract. More than 80% of the population reported the presence of a new
onset and persistent respiratory symptom. Dyspnea on exertion and cough were the most
common symptoms (68% and 57% of the total group respectively), although many described
chest tightness (46%) and wheeze (33%). The association of respiratory and non respiratory
symptoms with the high and low eos groups is shown in Figure 2. Eosinophil level was not
associated with presence of any LRS, however there was an association with a specific LRS
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since daytime and nocturnal wheeze was significantly increased in the high eos compared to
the low eos group (daytime wheeze: 46% vs. 31%; nocturnal wheeze: 34% vs. 20 %
respectively; p < 0.0001, Panel A). No significant difference between the high eos and low
eos group was identified for other specific symptoms of DOE, cough, or chest tightness.
Non LRS including nasal congestion, gastroesophageal reflux disease, headache and rash
were not associated with high eos (Fig. 2, Panel B).
We evaluated whether there was an association of peripheral eosinophils with severity of
asthma symptoms using frequency of symptoms or severity of symptoms described as mild,
moderate or severe (Fig. 3). Patients with high eos were more likely to have an increase in
wheezing frequency and wheeze severity with the percentage of high eos patients increasing
from 16.7% in the mild group to 22.3% in the severe group (Figure 3: Panel B, p for trend <
0.001).
Spirometry and LRS symptoms
Spirometry results were available for 1,160 patients (Table 2). Mean values for FVC, FEV1
and FEV1/FVC were within normal limits for the total population (data not shown). As a
whole, the majority of the population (75%) demonstrated a normal spirometry pattern with
an obstructive pattern in 9% of the population. The presence of wheeze was noted in 35% of
the study population, and was positively associated with an obstructive spirometry pattern
(OR 1.92 p < 0.002). New onset and persistent DOE was noted in 68% of the population and
was associated with a low FVC spirometry pattern (OR 1.54 p<0.02). Neither cough nor
chest tightness discriminated between any lung function patterns, and thus was not included
in subsequent analyses.
Spirometry and eosinophil levels
Spirometry results and eosinophil counts were available for 1,133 patients. There was no
significant association between high eos and a reduction in specific spirometry
measurements including FVC, FEV1 or FEV1/FVC. In contrast, as shown in Table 3, there
was an association between high eos and an obstructed spirometry pattern (OR 2.4 p<
0.0003). A significant bronchodilator response (200 ml increase in FEV1 and 12%
improvement in FEV1) was also associated with high eos compared to low eos group (34%
vs. 24%, p = 0.01). The presence of high eos was not associated with a low FVC spirometry
pattern.
Discussion
Many local residents, workers and individuals involved in the clean-up activities after the
destruction of the WTC towers on September 11, 2001 were exposed to WTC dust, gases,
and fumes. As has been described for firefighters and responders, community members have
commonly presented with diverse LRS and heterogeneous lung function patterns (15–16,
27). We now report the association of a specific LRS and an obstructive lung function
pattern with increased peripheral eosinophils suggesting a possible inflammatory
mechanism.
Kazeros et al. Page 5






















The finding of an increase in peripheral eosinophils in symptomatic WTC-exposed patients
is in accordance with the few descriptions of inflammatory responses in WTC-exposed
residents. A case report of a firefighter, and a study of WTC-firefighters compared to Israeli
firefighters both demonstrated eosinophils in the bronchoalveolar lavage and in induced
sputum (21–22). Our study, using a peripheral biomarker, is consistent with these studies
and suggests that in some patients with WTC-dust and fume exposure that occurred as a
result from exposure as a local worker, resident or clean-up worker, an eosinophilic process
may be present. The presence of eosinophils is consistent with the finding of elevated levels
of GM-CSF in serum from the firefighter population (28). The persistence of elevated
eosinophils and symptoms identified in this population 4–7 years after 9/11 suggests an
ongoing process.
The presence of increased peripheral eosinophils was associated with specific symptoms of
wheeze, but not DOE. Lower respiratory symptoms of wheeze have been suggested to have
high sensitivity for asthma in epidemiologic studies, although they are not diagnostic of
asthma (29). The finding of the association of elevated eosinophils with this symptom, but
not with overall LRS or symptoms of cough or chest tightness suggests but does not prove,
that eosinophils were associated with a more “asthma-like” syndrome in these patients.
Asthma is a heterogeneous disease with different phenotypes; occupational or irritant-
induced asthma is considered one phenotype (30–31). Elevated eosinophils, either identified
in induced sputum, bronchoalveolar lavage, or bronchial biopsy have been associated with
many, but not all adults and children with asthma (32) (33). A “low Th2” lymphocyte/
eosinophil and “high Th2“ lymphocyte/eosinophil asthmatic populations have also been
suggested based on microarray studies of brushed bronchial epithelial cells (31). A recent
multi-dimensional cluster analysis of common clinical factors and measurements
distinguished seven clinical subphenotypes, three of which demonstrated an eosinophil
predominance (30). In many asthmatics, eosinophilic inflammation has been associated with
airway basement membrane remodeling, bronchial hyperreactivity, spirometric parameters
of airflow obstruction, and physiologic and clinical improvements and fewer exacerbations
after treatment with inhaled corticosteroids (34–40). Thus these studies highlight the
importance of distinguishing specific phenotypes and underlying inflammatory types in
asthma, including those potentially caused by environmental exposures.
Occupational asthma, one asthma phenotype, can be further categorized into reactive-
airways dysfunction (RADS) and irritant-induced asthma. RADS involves the sudden onset
of asthma symptoms and signs after a single brief, high-level exposure to an irritant, gas, or
fume with resultant airflow obstruction and bronchial hyperresponsiveness (41–43). Irritant-
induced asthma typically requires a longer exposure period, often with multiple low-
moderate level exposures with a delayed onset of symptoms and signs of asthma which may
last for years. Irritant-induced asthma has been suggested to result from direct airway
epithelial damage with a subsequent release of pro-inflammatory mediators (44). A few case
reports or retrospective cohort studies of irritant-induced asthma resulting from a variety of
exposures suggest the presence of eosinophils although these findings have been
inconsistent (44–50). The pattern of exposure, often delay in onset of symptoms, and
presence of LRS has suggested the possible diagnosis of irritant induced asthma in many of
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the WTC-exposed community members and clean-up workers (4, 15, 51). In addition, the
presence of airway hyperreactivity in very limited studies also supports this diagnosis (1–2,
4, 23, 52).
Our data, using blood eosinophils as a biologic marker, suggest an eosinophilic process in
some patients with WTC exposure and symptoms. Interestingly eosinophils were most
strongly associated with the specific symptoms of wheeze and an obstructive pattern on
spirometry. These data suggest that WTC-related irritant-induced asthma may be associated
with an eosinophilic process, whereas the mechanisms responsible for other LRS may differ.
There are several potential limitations to our study. Most patients had normal spirometry and
we did not routinely perform methacholine testing. Thus we can only suggest a diagnosis of
asthma. This was a study of a population affected by an unplanned disaster. As such, we do
not have pre-existing lung function data and use self-report of symptoms. Thus we cannot
confirm the attribution of symptoms to WTC exposures but use the combination of reported
exposure, temporal association and pattern of symptoms, shown in previous epidemiologic
studies, to suggest a likely cause and effect. The quantification of eosinophils performed in
sputum and bronchoalveolar lavage has been suggested as a preferred biomarker in asthma
(53). We were a large clinical program, and thus evaluated only peripheral eosinophils.
Despite this, we detected an association of peripheral eosinophils and specific symptoms.
The quantification of eosinophil counts and percentages was performed with automated
systems, which may be less accurate than manual count but all patients were examined in
the same manner, thus providing a technical bias that would have affected all patients.
In summary, these data suggest a potential inflammatory mechanism for WTC-related lung
disease in a subpopulation of patients who present with symptoms consistent with an
obstructive lung pattern and suggests a potential mechanism for lung damage. Conversely,
in the remaining symptomatic individuals, a different pathophysiologic mechanism may be
invoked. Further exploration with multimodality testing and additional clinical phenotyping
will help clarify the mechanisms of disease in this considerable population of symptomatic
individuals with a unique environmental and occupational exposure.
Conclusions
Peripheral eosinophils were associated with wheeze and reduced lung function in a diverse
WTC-exposed population. These data suggest that eosinophils may participate in lung
inflammation in this population with symptoms consistent with WTC-related asthma.
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World Trade Center Environmental Health Center (WTC EHC) Population enrolled.
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Comparison of symptoms in the high and low eosinophil groups. Percent of individuals in high and low eos groups with A:
respiratory symptoms B: non-respiratory symptoms.
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Wheezing severity and eosinophil group. Percent of population with wheezing severity categorized as A: number of days/week
with wheezing, and B: description of severity. p values <0.05 significant.
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Table 1
Characteristics of the WTC EHC population with new onset and persistent lower respiratory symptoms as
whole and stratified by eosinophil percentage
Total High Eos Low Eos P value**
n = 1,508 n = 216 n = 1,192
Gender, n (%)
  Male 740 (49) 127 (59) 566 (47) 0.002
  Female 768 (51) 89 (41) 626 (53)
Age, mean ± SE 46.4 ± 0.3 44.7 ± 0.9 46.7 ± 0.4 0.03
BMI, mean ±SE 28.2 ± 0.2 28.0 ± 0.4 28.2±0.2 0.62
Race/Ethnicity, n (%)
  Non-Hispanic White 393 (26) 47 (22) 309 (26) 0.70
  Non-Hispanic Black 226 (15) 31 (14) 176 (15)
  Hispanic 678 (45) 108 (50) 541 (45)
  Asian 178 (12) 25 (12) 141 (12)
  No answer 33 (2) 5 (2) 25 (2)
Exposure category, n (%)
  Clean-up worker 441(29) 66 (31) 361 (30) NS
  Rescue and Recovery 82 (5) 14 (6) 65 (5)
  Resident 289 (19) 34 (16) 231 (19)
  Local worker 869 (37) 81 (38) 445 (37)
  Other 126 (8) 21 (10) 89 (7)
Dust cloud exposure, n (%)
  Yes 622 (42) 94 (45) 494 (42) NS
  No 853 (58) 117 (55) 673 (58)
*
100 patients did not have phlebotomy performed; 1 subject missing exposure category; dust cloud data missing in 33 subjects
**
Univariate analysis with t-test or chi-square
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